TobaccoIntelligence

Regulatory & market intelligence for alternative tobacco & nicotine products

Regulatory briefing

FDA rejects snus as modified risk – but could reconsider some aspects

Written by || 14th December 2016 || Regulatory briefing | Snus and oral | North America United States

Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus smokeless tobacco products classified as modified risk ...

Restricted content. Do you want to read more?

Read our latest free content

Is plain packaging of snus working in Norway? Official body raises the question
US FDA authorises sale of oral tobacco products taken off the market in 2019
Decision on e-cigs shines some light on US FDA’s likely approach to alternatives
PMI’s heated tobacco business on the up despite warnings of disruption in US
Patents for HnB and smokeless tobacco products on the rise, research finds
‘Utopian’ – but is a global consensus on smoke-free alternatives a realistic goal?

Featured topic

The shift of the Mexican government toward allowing the sale of these smoke-free devices

A step forward on heated tobacco taken by the US Food and Drug Administration (FDA)

Blog| Regulatory Briefing | Heated tobacco

Sign up to our newsletter

By signing up you agree to our Terms and Conditions